On August 31, 2012, Regeneron Pharmaceuticals (REGN) had a market capitalization of $17.1B, based on 115.83M shares at a price of $147.23.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
August 31 2012 | $147.23 | 690,500 | 115,830,000 | $17,054,044,722.00 |
August 30 2012 | $144.71 | 695,300 | 115,830,000 | $16,761,458,142.00 |
August 29 2012 | $144.68 | 413,800 | 115,830,000 | $16,758,006,408.00 |
August 28 2012 | $145.96 | 659,800 | 115,830,000 | $16,906,604,715.00 |
August 27 2012 | $144.69 | 526,800 | 115,830,000 | $16,759,153,125.00 |
August 24 2012 | $144.29 | 627,300 | 115,830,000 | $16,713,075,951.00 |
August 23 2012 | $141.99 | 1,355,200 | 115,830,000 | $16,446,991,275.00 |
August 22 2012 | $137.94 | 818,200 | 115,830,000 | $15,977,011,050.00 |
August 21 2012 | $133.88 | 489,400 | 115,830,000 | $15,507,030,825.00 |
August 20 2012 | $135.68 | 356,000 | 115,830,000 | $15,715,524,825.00 |
August 17 2012 | $137.30 | 370,800 | 115,830,000 | $15,903,285,255.00 |
August 16 2012 | $136.72 | 500,500 | 115,830,000 | $15,836,474,511.00 |
August 15 2012 | $136.82 | 659,900 | 115,830,000 | $15,847,999,596.00 |
August 14 2012 | $135.19 | 435,700 | 115,830,000 | $15,659,080,866.00 |
August 13 2012 | $134.61 | 769,000 | 115,830,000 | $15,592,270,122.00 |
August 10 2012 | $136.09 | 481,600 | 115,830,000 | $15,762,748,716.00 |
August 09 2012 | $137.05 | 450,900 | 115,830,000 | $15,874,489,917.00 |
August 08 2012 | $138.86 | 594,800 | 115,830,000 | $16,084,142,217.00 |
August 07 2012 | $138.71 | 622,900 | 115,830,000 | $16,066,860,381.00 |
August 06 2012 | $136.69 | 443,700 | 115,830,000 | $15,833,022,777.00 |
August 03 2012 | $136.20 | 678,900 | 115,830,000 | $15,776,578,818.00 |
August 02 2012 | $135.72 | 573,000 | 115,830,000 | $15,720,134,859.00 |
August 01 2012 | $133.27 | 769,400 | 115,830,000 | $15,436,768,347.00 |
